Related Experiment Video
Updated: Mar 11, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson's Disease
Lauren Heusinkveld1,2, Mallory Hacker1, Maxim Turchan1
1Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Abstract:
The FDA has approved a multicenter, double-blind, Phase III, pivotal trial testing deep brain stimulation (DBS) in 280 people with very early stage Parkinson's disease (PD; IDE#G050016). In partnership with The Michael J. Fox Foundation for Parkinson's Research, we conducted a survey to investigate motivating factors, barriers, and gender differences among potentially eligible patients for participation in a trial testing DBS in early PD compared to standard medical treatment. The majority of survey respondents (72%) indicated they would consider learning more about participating. Early PD patients are therefore likely to consider enrolling in trials of invasive therapies that may slow symptom progression and help future patients.
Insights
Most early-stage Parkinson's disease patients are open to learning about deep brain stimulation (DBS) trials. This suggests potential for recruiting participants for invasive therapies aimed at slowing symptom progression.
Area of Science:
- Neurology
- Neurosurgery
- Clinical Trials
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder.
- Deep brain stimulation (DBS) is an emerging invasive therapy for PD.
- Early-stage PD patient enrollment in invasive therapy trials requires investigation.
Purpose of the Study:
- To survey potential participants for a Phase III trial of DBS in early PD.
- To identify motivating factors and barriers to trial participation.
- To explore gender differences in patient considerations for DBS trials.
Main Methods:
- A survey was conducted among individuals with early-stage PD.
- The survey focused on motivations, barriers, and gender differences regarding DBS trial participation.
- The study was conducted in partnership with The Michael J. Fox Foundation for Parkinson's Research.
Main Results:
- 72% of survey respondents expressed willingness to learn more about trial participation.
- Early-stage PD patients are likely to consider invasive therapy trials.
- Motivating factors and barriers were identified, with gender differences noted.
Conclusions:
- Early-stage Parkinson's disease patients are receptive to information about DBS clinical trials.
- Patient willingness to consider invasive therapies suggests feasibility for trial recruitment.
- Understanding patient perspectives is crucial for advancing PD treatment research.
More Related Videos
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview